title: Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs.
abstract: The pharmacokinetics of 5-fluorouracil (FUra) were studied alone and in the presence of either bromodeoxyuridine (BrdUrd) or iododeoxyuridine (IdUrd) in five mixed breed hounds. FUra was administered intravenously over 1 min as a 5 mg/kg dose in all three treatments. BrdUrd or IdUrd was infused intravenously at 2.5 mg/hr.kg x 6 hr and FUra was given 3 hr into the 6-hr infusion of thymidine analog. Serial blood samples were obtained for 3 hr prior to and after FUra dosing. Plasma concentrations of FUra, BrdUrd and bromouracil (BrUra), and IdUrd and iodouracil (IUra) were measured by reversed-phase HPLC. Concomitant administration of BrdUrd or IdUrd resulted in substantial changes in the kinetics of FUra. In particular, the total plasma clearance of FUra was decreased and area under the plasma concentration-time curve was increased. There were also significant changes in the volume of distribution steady-state, and in the mean residence time and half-life of FUra. The data show that FUra had little or no effect on the disposition of BrdUrd or IdUrd. In contrast, FUra had a significant effect on the disposition of BrUra and IUra going to form catabolic products. The observed pharmacokinetic interaction in dogs is probably due to a competition between BrUra (or IUra) and FUra for the rate-limiting catabolic enzyme, dihydropyrimidine dehydrogenase. This kinetic interaction was mutual and of a smaller magnitude for FUra + BrdUrd than for FUra + IdUrd.
authors.affiliation: College of Pharmacy, University of Michigan, Ann Arbor 48109-1065.
authors.forename: D E
authors.initials: DE
authors.lastname: Smith
authors.forename: D E
authors.initials: DE
authors.lastname: Brenner
authors.forename: C A
authors.initials: CA
authors.lastname: Knutsen
authors.forename: S J
authors.initials: SJ
authors.lastname: Deremer
authors.forename: P A
authors.initials: PA
authors.lastname: Terrio
authors.forename: N J
authors.initials: NJ
authors.lastname: Johnson
authors.forename: P L
authors.initials: PL
authors.lastname: Stetson
authors.forename: W D
authors.initials: WD
authors.lastname: Ensminger
mesh_terms: D000818:Animals; D001973:Bromodeoxyuridine / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D004285:Dogs; D004347:Drug Interactions; D005472:Fluorouracil / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D006207:Half-Life; D007065:Idoxuridine / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D007262:Infusions, Intravenous; D007275:Injections, Intravenous
chemical_list: D001973:Bromodeoxyuridine; D007065:Idoxuridine; D005472:Fluorouracil